Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lea Knez
Observed names:
Knez, Lea,
L. Knez,
LEA KNEZ
Institutions:
University of Ljubljana,
University Clinic of Pulmonary and Allergic Diseases Golnik,
University Clinical Centre Maribor,
Institut für Schlaganfall- und Demenzforschung,
Ludwig-Maximilians-Universität München
Observed institutions:
University of Ljubljana,
Royal London Hospital,
University Clinic of Pulmonary and Allergic Diseases Golnik,
University Clinical Centre Maribor,
Institut für Schlaganfall- und Demenzforschung,
Ludwig-Maximilians-Universität München
show all 6
ORCID:
0000-0002-7743-2827
Observed ORCIDs:
0000-0002-7743-2827,
0009-0006-6555-9536
OpenAlex ID:
A5090012753
The need for medication reconciliation: a cross-sectional observational study in adult patients
2011
·
Lea Knez
, Stanislav Suskovic
, et al.
·
Respiratory Medicine
·
64
PDF
Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting
2012
·
Mirko Lekic
, Viljem Kovac
, et al.
·
Radiology and Oncology
·
47
PDF
Oral treatment with etoposide in small cell lung cancer – dilemmas and solutions
2013
·
Renata Rezonja
, Lea Knez
, et al.
·
Radiology and Oncology
·
46
PDF
Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial
2024
·
Maja Jošt
, Mojca Kerec Kos
, et al.
·
Frontiers in Pharmacology
·
45
PDF
Update on systemic therapy of advanced non-small-cell lung cancer
2014
·
Tanja Cufer
, Lea Knez
·
Expert Review of Anticancer Therapy
·
37
Evaluation of clinical interventions made by pharmacists in chemotherapy preparation
2010
·
Lea Knez
, Raisa Laaksonen
, et al.
·
Radiology and Oncology
·
32
PDF
Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: A systematic review
2011
·
Lea Knez
, Eva Sodja
, et al.
·
Lung Cancer
·
29
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center
2021
·
Marija Ivanović
, Lea Knez
, et al.
·
The Oncologist
·
26
PDF
Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
2023
·
Veronika Pelicon
, Tanja Cufer
, et al.
·
Frontiers in Oncology
·
24
Time to access to novel anticancer drugs and the correlation with ESMO-Magnitude of Clinical Benefit Scale in Slovenia
2019
·
Urska Janzic
, Lea Knez
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
21
Adverse drug events during transitions of care: Randomized clinical trial of medication reconciliation at hospital admission
2021
·
Maja Jošt
, Lea Knez
, et al.
·
Wiener klinische Wochenschrift
·
19
Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer
2016
·
Nina Turnšek Hitij
, Izidor Kern
, et al.
·
Clinical Lung Cancer
·
19
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
2012
·
Eva Sodja
, Lea Knez
, et al.
·
European Journal of Cancer
·
18
Comprehensive medication history: the need for the implementation of medication reconciliation processes
2010
·
Renata Režonja
, Lea Knez
, et al.
·
Slovenian Journal of Public Health
·
17
PDF
Pharmacist-led hospital intervention reduces unintentional patient-generated medication discrepancies after hospital discharge
2024
·
Maja Jošt
, Lea Knez
, et al.
·
Frontiers in Pharmacology
·
10
PDF
Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
2012
·
L. Knez
, M. Košnik
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
10
Estimation of renal function in lung cancer patients
2011
·
Katja Trobec
, Lea Knez
, et al.
·
Lung Cancer
·
10
Improving the feasibility of deprescribing proton pump inhibitors: GPs’ insights on barriers, facilitators, and strategies
2024
·
Nuša Japelj
, Lea Knez
, et al.
·
Frontiers in Pharmacology
·
9
PDF
Deprescribing: An umbrella review
2024
·
Nuša Japelj
, Nejc Horvat
, et al.
·
Acta Pharmaceutica
·
9
PDF
A human iPSC model of tauopathies engineered for 4R tau isoform expression endogenously develops late-stage neuronal tau pathology
2026
·
Angelika Dannert
, Nathalie Schulz
, et al.
·
Science Translational Medicine
·
8
Evaluation of clinical interventions made by pharmacists in cancer services
2008
·
Lea Knez
, Raisa Laaksonen
, et al.
·
Pharmaceutical journal/The pharmaceutical journal
·
7
Deprescribing proton pump inhibitors: A study in hospitalized patients in Slovenia
2023
·
Nina Ravbar
, Mojca Kerec Kos
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
4
Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors
2022
·
Jurij Aguiar Zdovc
, Mihaela Vaupotič
, et al.
·
Cancer Chemotherapy and Pharmacology
·
4
Timing and intensity of proton pump inhibitor exposure hampers overall survival in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors: a retrospective cohort study
2026
·
Nuša Japelj
, Nejc Horvat
, et al.
·
Frontiers in Immunology
·
2
PDF
421P: Antibiotic prescription patterns and their association with outcomes in patients with advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICI)
2025
·
L. Knez
, L. Rus
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Show more works
View as search
Works count:
47
Citation count:
529
H-index:
14
I10-index:
17
Year
Topic
Type